Champions Oncology Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Revenue	56.94	50.16	53.87	49.11	41.04	Upgrade
Revenue Growth (YoY)	13.54%	-6.90%	9.70%	19.66%	27.76%	Upgrade
Cost of Revenue	28.39	29.4	29.53	23.63	21.45	Upgrade
Gross Profit	28.56	20.75	24.34	25.48	19.59	Upgrade
Selling, General & Admin	16.88	18.13	17.24	15.5	12.03	Upgrade
Research & Development	6.83	9.54	11.55	9.37	7.2	Upgrade
Operating Expenses	23.71	27.68	28.79	24.87	19.23	Upgrade
Operating Income	4.85	-6.92	-4.45	0.61	0.37	Upgrade
Interest Expense	-0.03	-0.03	-	-	-	Upgrade
Interest & Investment Income	0.09	0.09	-	-	-	Upgrade
Currency Exchange Gain (Loss)	0.01	-0.02	-0.01	-0.02	-0.01	Upgrade
Other Non Operating Income (Expenses)	0	-	-	-	-	Upgrade
EBT Excluding Unusual Items	4.92	-6.87	-4.46	0.58	0.36	Upgrade
Gain (Loss) on Sale of Assets	-0.29	-0.44	-	-	-	Upgrade
Asset Writedown	-	-	-0.81	-	-	Upgrade
Other Unusual Items	-	-	-	-	0.08	Upgrade
Pretax Income	4.63	-7.31	-5.27	0.58	0.44	Upgrade
Income Tax Expense	-0.08	-0.03	0.07	0.04	0.08	Upgrade
Net Income	4.7	-7.28	-5.34	0.55	0.36	Upgrade
Net Income to Common	4.7	-7.28	-5.34	0.55	0.36	Upgrade
Net Income Growth	-	-	-	51.38%	-	Upgrade
Shares Outstanding (Basic)	14	14	14	13	13	Upgrade
Shares Outstanding (Diluted)	14	14	14	14	15	Upgrade
Shares Change (YoY)	5.31%	0.04%	-4.37%	-2.84%	23.05%	Upgrade
EPS (Basic)	0.34	-0.54	-0.39	0.04	0.03	Upgrade
EPS (Diluted)	0.33	-0.54	-0.39	0.04	0.02	Upgrade
EPS Growth	-	-	-	100.01%	-	Upgrade
Free Cash Flow	7	-6.97	1.1	4.11	-4.96	Upgrade
Free Cash Flow Per Share	0.49	-0.52	0.08	0.29	-0.34	Upgrade
Gross Margin	50.15%	41.38%	45.18%	51.88%	47.74%	Upgrade
Operating Margin	8.51%	-13.80%	-8.26%	1.24%	0.89%	Upgrade
Profit Margin	8.25%	-14.51%	-9.90%	1.12%	0.88%	Upgrade
Free Cash Flow Margin	12.29%	-13.90%	2.04%	8.38%	-12.09%	Upgrade
EBITDA	6.49	-5.05	-2.83	2.23	1.55	Upgrade
EBITDA Margin	11.39%	-10.08%	-5.26%	4.55%	3.78%	Upgrade
D&A For EBITDA	1.64	1.87	1.62	1.63	1.18	Upgrade
EBIT	4.85	-6.92	-4.45	0.61	0.37	Upgrade
EBIT Margin	8.51%	-13.80%	-8.26%	1.24%	0.89%	Upgrade
Effective Tax Rate	-	-	-	6.00%	17.16%	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q